InVivo Therapeutics
+$0.0344 (+8.02%) Today
+$0.0045 (+0.97%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVIV and other ETFs, options, and stocks.
About NVIV
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord.
CEO
Richard Toselli
Employees
6
Headquarters
Cambridge, Massachusetts
Founded
2005
NVIV Key Statistics
Market cap
15.88M
Price-Earnings ratio
—
Dividend yield
—
Average volume
410.67K
High today
$0.47
Low today
$0.42
Open price
$0.4321
Volume
650.49K
52 Week high
$2.00
52 Week low
$0.42
NVIV Earnings
-$0.49
-$0.10
$0.30
$0.69
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 1, After Hours